• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions
  • All Diseases and Conditions

The following clinical trials are associated with All diseases and conditions.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next
  • expand A Phase 3, randomised, open-label, crossover study to compare HFA vs CFC pMDI formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, mild to moderate asthma
    Study Id
    D5252C00008
    Disease
    asthma
    Drug Name
    Pulmicort
    Study Name
    D5252C00008
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Oct 19, 2009
    • D5252C00008.pdf (218 KB)
  • expand Phase II, Open Label, Non-Randomized Study of AZD2281 in the Treatment of Patients with Known BRCA or Recurrent High Grade Serous/ Undifferentiated Tubo-Ovarian Carcinoma and in Known BRCA or Triple Negative Breast Cancer to Determine Response Rate and Correlative Markers of Response
    Study Id
    D0810C00020
    Disease
    breast cancer, ovarian cancer
    Drug Name
    Olaparib
    Study Name
    D0810C00020
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand The use of a forecasting system for predicting exacerbations of COPD: effect on symptoms and hospitalisation and relevance of viral infections
    Study Id
    D6256M00017
    Disease
    chronic obstructive pulmonary disease
    Drug Name
    non drug study (respiratory)
    Study Name
    D6256M00017
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Faslodex Post Marketing Surveillance
    Study Id
    D6997L00018
    Disease
    breast cancer
    Drug Name
    Faslodex
    Study Name
    D6997L00018
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A single-centre, double-blind, randomised, parallel group study of repeated oral doses of AZD3480/placebo and a single dose of aripiprazole to evaluate the pharmacokinetic interaction between AZD3480 and aripiprazole in healthy subjects (phase I)
    Study Id
    D3691C00001
    Disease
    schizophrenia, Alzheimer's Disease
    Drug Name
    AZD3480
    Study Name
    D3691C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A single-centre, double blind, randomised, two-way cross-over study of repeated doses of AZD3480 and single dose of warfarin to evaluate the pharmacokinetic interaction of AZD3480 and warfarin and the effect of AZD3480 pharmacodynamic in healthy male subjects (phase I)
    Study Id
    D3690C00014
    Disease
    schizophrenia, Alzheimer's Disease
    Drug Name
    AZD3480
    Study Name
    D3690C00014
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A double-blind, randomised, cross-over, placebo-controlled study of repeated oral doses of AZD3480 and a single dose of donepezil to evaluate the pharmacokinetic interaction between AZD3480 and donepezil in healthy extensive and poor metabolisers of CYP2D6
    Study Id
    D3690C00005
    Disease
    schizophrenia, Alzheimer's Disease
    Drug Name
    AZD3480
    Study Name
    D3690C00005
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Malignancies
    Study Id
    D2610C00001
    Disease
    cancer
    Drug Name
    AZD4547
    Study Name
    D2610C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD2423 After Single Ascending Doses in Healthy Japanese Male and Non-Fertile Female Volunteers
    Study Id
    D2600C00003
    Disease
    analgaesia
    Drug Name
    AZD2423
    Study Name
    D2600C00003
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD2423 Solution After Multiple Ascending Doses in Young and Elderly Healthy Volunteers
    Study Id
    D2600C00002
    Disease
    analgaesia
    Drug Name
    AZD2423
    Study Name
    D2600C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013